Tag: ACCURATE FORECASTS

Ten months ago, in March, 2021, we wrote that The Trade Desk stock can “exceed $1000, but not by much.” Shares were hovering around...

Snapchat is famous for deleting all messages sent over the platform immediately after they’ve been viewed by the recipient. And while this feature is...

Sales at online marketplace giant Etsy are on track for a 33% gain in 2021 and are expected to add at least 20% more...

Even though the stock recouped most of yesterday’s losses, Lululemon still disappointed investors with its Q421 guidance. Despite causing a milder illness, the Omicron...

It’s been roughly a month since the new Omicron variant emerged and threatened to bring back curbs to slow its spread. The...

In late-September, 2021, USDCAD had already spent over two months in a narrowing sideways range. Despite occasionally breaching the 1.2900 mark during...

We last wrote about Roku in the spring, on May 24th, 2021. The stock was hovering around $330 a share. Fundamentally speaking, we thought...

Our first and only article on NovoCure stock was published almost three months ago, on July 1st. In it we shared our view that...

When we wrote our previous article on Danish jewelry maker Pandora in December, 2020, the stock was up over three-fold since March. That recovery...

We first wrote about CBOE Global Markets less than eight months ago. The S&P 500 had already recouped all its COVID selloff losses and...

USDCAD rose significantly this past week, climbing from 1.2512 at the open to as high as 1.2949 Friday. The surge can be attributed to...

Buying shares in a beauty retailer in March 2020 sounded like a crazy, stupid idea. Stock markets around the world were plunging at a...

Economic and fiscal steps taken to help the global economy rebound from the COVID-19 crisis are still in effect in both U.S....

The last time we wrote a free article about Bitcoin was on May 13th. The price of the biggest cryptocurrency had just...

The first and only time we wrote about LKQ Corporation was in late-September, 2020. The stock had just doubled from its coronavirus plunge and...

It was March 19th, 2020, and the world appeared to be coming to an end. Governments around the globe were rushing to impose lockdowns...

We first wrote about Alteryx in the fall of 2020. The stock was surging after a better-than-expected Q3 revenue guidance and was quickly approaching...

Tesla CEO Elon Musk announced the company would stop accepting Bitcoin as payment due to environmental concerns. The EV-maker’s Bitcoin stunt lasted...

We first wrote about Rapid7 in late-August 2019. The stock was hovering above $55.50, but the structure of the post-2016 uptrend suggested a notable...

Earnings at PNC Financial suffered last year along with the entire financial sector. Net income before extraordinary items came in at $2.95B in 2020,...

The first time we wrote about 3i Group was in late-October 2019. The stock was hovering around 1100 pence a share following a 1000%...

We find it hard to describe the past twelve months. What a year it’s been. A little over a year ago, the world was...

Hibbett Sports Inc. is an American sporting goods retailer with more than 1000 stores in over 30 states. We first wrote about the company...

Overall, 2020 was a good year for EURUSD bulls. Despite the March crash during the coronavirus-related volatility, the pair ended the year...

The crude oil market is capable of going from a state of oversupply to one of not enough supply in relatively short...

We first wrote about Interpublic in March 2018. The stock had just reached $26 a share, but we thought an Elliott Wave correction can...

We last wrote about Expedia in mid-2020. Countries around the globe had mostly closed their borders, the COVID-19 vaccine was still just a hopeful...

We first wrote about Steel Dynamics on January 16th, 2020. The stock was trading near $33 a share, down from its May 2018 record...

2020 wasn’t a good year for USDJPY bulls. Starting from 108.63 in January, the pair closed at 103.32 on December 31st, down...

We first covered Horizon Therapeutics, then Horizon Pharma, in September 2016. The stock was trading around $18 a share after a decline from the...